Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis. - Canales E; Tse W; Schroeder SD; Chou CH; Liu Q; Zhang J; Lazerwith SE; Morganelli P; Saito RD; Brizgys G; Li J; Wu Q; et al. (Journal of medicinal chemistry, 2025)